PET using 18F-FDG is increasingly used for the diagnosis and grading of tumors. Several
studies have been performed that evaluate the diagnostic and grading performance of 18F …

The purpose of this study was to evaluate 18F-FDG PET studies of primary and recurrent
sarcomas for diagnosis and correlation with grading. Methods: The evaluation included 56 …

Purpose The usefulness of 18 F-fluorodeoxyglucose positron emission tomography (18 F-
FDG PET) for the survival prognosis in soft tissue sarcoma (STS) and bone sarcoma (BS) is …

Purpose We aimed to evaluate the value of [68 Ga] Ga-DOTA-FAPI-04 PET/CT for the
diagnosis of recurrent soft tissue sarcoma (STS), compared with [18F] FDG PET/CT …

Background The use of 18 F-FDG Positron emission tomography/Computed tomography
(PET/CT) in the initial staging of many cancers is clearly established. Most soft tissue …

Purpose To assess and compare the diagnostic accuracy of PET/MRI and MRI alone for the
detection of local recurrences of soft tissue sarcomas (STS) after initial surgical resection of …

Background The use of 18 F-FDG PET–CT (PET–CT) is widespread in many cancer types
compared to sarcoma. We report a large retrospective audit of PET–CT in bone and soft …

Purpose To evaluate the feasibility of 18 F-FDG PET/CT for initial assessment in high-grade
bone sarcomas (BS) and soft tissue sarcomas (STS). Methods During the years 2001–2010 …

Background: Sarcomas represent a significant diagnostic and therapeutic challenge that
requires techniques to provide better assessment of the disease than provided by traditional …

Purpose Twelve years ago a meta-analysis evaluated the diagnostic performance of 18 F-
fluorodeoxyglucose (FDG) positron emission tomography (PET) in assessing …